Cellectis (CLLS) Change in Intangibles (2015 - 2025)
Cellectis (CLLS) recorded quarterly Change in Intangibles of -$1.2 million in Q3 2025, down 4050.0% quarter-over-quarter from -$28000.0 in Q3 2024, and down 4050.0% on a YoY basis from $29417.7 in Q3 2024.
Cellectis (CLLS) Change in Intangibles (2015 - 2025) Analysis & Trends
Cellectis' Change in Intangibles history runs 10 years deep, the most recent figure standing at -$1.2 million for Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.96 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.16 Mn |
| Sep 30, 2025 | -1.16 Mn |
| Sep 30, 2024 | -28,000.00 |
| Sep 30, 2024 | -28,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Mar 31, 2024 | -37,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Sep 30, 2022 | -163,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Sep 30, 2021 | -857,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -22,000.00 |
| Mar 31, 2021 | -22,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Sep 30, 2020 | -2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | -43,000.00 |
| Mar 31, 2020 | -43,000.00 |